Robyn Coward is the Life Sciences Director at QAD. With 21 years of experience in product commercialization, Robyn has spent the last 11 years focused on the global life sciences markets, particularly in the imaging, laboratory diagnostics, and healthcare IT segments. In her role, Robyn monitors and reports on the trends impacting QAD's life sciences customers. She is a member of several industry organizations including the Medical Device Contract Manufacturing Trends Group, Life Sciences Technology and Compliance Group, and the Healthcare Businesswomen's Association. Robyn also participates in various Biocom Institute activities, and enjoys residing in the San Francisco Bay area, one of the world's top hubs for biotechnology, pharmaceutical and medical device development and manufacturing, where she can see exciting and emerging healthcare innovations before they hit the market.